Jaringan Laboratorium Medis

Vol. 5 No. 2 (2023): November 2023
Original Articles

Comparison of The Percentage of The Risk of Death in TBC Comorbid Patients with Other Comorbids in Pati District

PDF
  • Randi Eka Istananta,
  • Teguh Budihardjo,
  • Surati
Randi Eka Istananta
Poltekkes Kemenkes Semarang
Teguh Budihardjo
Poltekkes Kemenkes Semarang
Surati
Poltekkes Kemenkes Semarang

Published 2023-12-11

Copyright (c) 2023 Jaringan Laboratorium Medis

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

How to Cite

Comparison of The Percentage of The Risk of Death in TBC Comorbid Patients with Other Comorbids in Pati District. (2023). Jaringan Laboratorium Medis, 5(2), 129-135. https://doi.org/10.31983/jlm.v5i2.9829

CrossMark



Dimensions

If it doesn't Appear, click here



PlumX Metrics



Impact Factor

or, Visit on here

Abstract

Corona Virus Disease 2019 (COVID-19) is a disease that has never previously been found in humans and is a new type of disease. The virus that causes COVID-19 is called Sars-CoV-2. It was found that patients experienced increased mortality due to COVID-19 because they had comorbid diseases. COVID-19 patients who have one comorbid disease are at risk of death up to 6.5 times higher than COVID-19 patients without comorbidities. Pulmonary TB is a comorbidity that can make a person more susceptible to contracting COVID-19 with severe symptoms. Apart from attacking the lungs, COVID-19 also damages the lungs. Damaged lungs prevent the body's organs from getting enough oxygen, which can trigger organ damage that can cause death. The aim of this study was to compare the percentage risk of death in COVID-19 patients who had comorbid TB disease with COVID-19 patients who had comorbid kidney disease and DM in the Pati area, Central Java. This research can be a reference for data regarding the percentage risk of death in COVID-19 patients with comorbidities. This research uses a descriptive, observational research design. The samples in this study were COVID-19 sufferers who had comorbid TB, comorbid kidney disease and comorbid DM. The sample population during the period January to December 2021 was 998. The sample was determined using the Slovin formula with a total of 135 samples with a sampling quota taken. Results Comorbid TB has a percentage risk of death of 40%, comorbid kidney has a percentage risk of death of 33.3%, and comorbid DM has a percentage risk of death of 6.8%. Comorbid TB is a comorbid that has the highest percentage risk of death, so intensive care is important for sufferers.

PDF

Downloads

Download data is not yet available.

References

  1. Aggarwal AN, Agarwal R, Dhooria S, Prasad KT, Sehgal IS, Muthu V. (2021). Active pulmonary tuberculosis and coronavirus disease 2019: A systematic review and meta-analysis. Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India. https://doi.org/10.1371/journal.pone.0259006
  2. Alkautsar, A. (2021). Hubungan Penyakit Komorbid Dengan Tingkat Keparahan Pasien Covid-19. Jurnal Medika Hutama, 3(01 Oktober), 1488-1494. Retrieved from https://jurnalmedikahutama.com/index.php/JMH/article/view/302
  3. Cahyaningtyas, T., Maruti, E., & Yunianto, T. (2021). Penyuluhan Tbc Dan Covid-19 Pada Ibu Pkk Desa Teguhan Kecamatan Jiwan Kabupaten Madiun. Indonesian JournalOf Community Service. http://ijocs.rcipublisher.org/index.php/ijocs/article/view/116
  4. Chen, Yu. et. all. (2020). Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. CC-BY-NC-ND 4.0 International. https://doi.org/10.1101/2020.03.10.20033795
  5. Damayanti, M., & Surati. (2020). Gambaran Kadar SGPT pada Pasien Tuberculosis Multidrug Resistant. Jurnal Laboratorium Medis, 02(02), 68–74. Retrieved from https://ejournal.poltekkes-smg.ac.id/ojs/index.php/JLM/%0A69
  6. Damayanti, Hikmatul. & Budoyono C. (2021). Pengaruh Vitamin C, Vitamin D, dan Zinc Terhadap COVID-19. Jurnal Kedokteran Unram. https://doi.org/10.29303/jku.v10i4.597
  7. Drew, Clement; Adisasmita, Asri C. (2021). Gejala dan komorbid yang memengaruhi mortalitas pasien positif COVID-19 di Jakarta Timur, Maret-September 2020. Tarumanagara Medical Journal. https://journal.untar.ac.id/index.php/tmj/article/view/11742
  8. Fauzia, Nikma Syalsabiela. (2021). Faktor Risiko Terjadinya Coronavirus Disease 2019 pada Pasien dengan Komorbid Diabetes Melitus. Jurnal Ilmu Kesehatan. https://doi.org/10.37148/arteri.v2i4.177
  9. Gunawan, Arif; dkk. (2020). Pengaruh komorbid hipertensi terhadap severitas pasien coronavirus disease 2019. Jurnal implementa husada. http://dx.doi.org/10.30596%2Fjih.v1i2.4972
  10. Hasanah, Nurul. (2021). Analisis prevalensi komorbid dengan kematian pasien COVID – 19 di kabupaten bangkalan. Keperawatan stikes ngudia husada madura. http://repository.stikesnhm.ac.id/id/eprint/953/
  11. Hikmawati, Isna. & Setiyabudi, Ragil. (2020). Hipertensi Dan Diabetes Militus Sebagai Penyakit Penyerta Utama Covid-19 Di Indonesia. Diakses melalui https://semnaslppm.ump.ac.id/index.php/semnaslppm/article/view/224/219
  12. Kahar, F., Dirawan, G. D., Samad, S., Qomariyah, N., & Purlinda, D. E. (2020). The Epidemiology of COVID-19, Attitudes and Behaviors of the Community During the Covid Pandemic in Indonesia. International Journal of Innovative Science and Research Technology, 5(8), 1681–1687. https://doi.org/10.38124/ijisrt20aug670
  13. Kahar, F., Purlinda, D. E., & Setyowatiningsih, L. (2022). Profil Diabetes Mellitus Pada Penderita Tuberculosis. Prosiding Seminar Nasional UNIMUS, 5, 1086–1095.
  14. Kahar, F., Widarti, & Wikandari, R. J. (2022). Respondent Characteristics and Student Health Knowledge About Covid-19. Journal for ReAttach Therapy and Developmental Diversities, 5(1), 28–40.
  15. Kahar, F., & Wikandari, R. J. (2022). Knowledge and COVID-19 prevention behavior : A case study of medical laboratory technology students in Indonesia. International Journal of Health Sciences, 6(S1), 7428–7442.
  16. Masitah, I. N. (2022). Profil Mikroskopis BTA pada Sputum Keluarga Pasien Terdiagnosa BTA Positif Fase Lanjutan. Jaringan Laboratorium Medis, 04(01), 31–36.
  17. Maciel, Ethel Leonor Noia, et. all. (2020). Tuberculosis and coronavirus: what do we know?. Epidemiol. Serv. Saude, Brasília. http://dx.doi.org/10.5123/s1679-49742020000200010
  18. Maftuhah, Laelatul. (2021). Gambaran biaya langsung medis pada pasien COVID-19 dengan komorbid di instalasi rawat inap rsud provinsi ntb tahun 2020. Universitas Muhammadiyah Mataram. http://repository.ummat.ac.id/id/eprint/3976
  19. Novitasari, P. A., Kahar, F., & Irnawati, I. (2022). Gambaran Kepositifan Basil Tahan Asam Pasien Diagnosis Klinis Tuberculosis Paru di Balai Kesehatan Masyarakat Semarang. Jurnal Laboratorium Medis, 04(02), 95–100. Retrieved from https://ejournal.poltekkes-smg.ac.id/ojs/index.php/JLM/
  20. Satria, Raden., Tutupoho, R., & Chalidyanto, D. (2020). Analisis faktor risiko kematian dengan penyakit komorbid COVID-19. Jurnal Keperawatan Silampari, 4(1), 48-55. https://doi.org/https://doi.org/10.31539/jks. v4i1.1587
  21. Suharyati, & Widiyanto, S. Y. D. (2019). Blood Glucose Levels in Patients with Lung Tuberculosis with Positive Acid Resistant Bacteria. JAringan Laboratorium Medis, 01(01), 42–45.
  22. The TB/COVID-19 Global Study Group. (2021). Tuberculosis and COVID-19 co-infection: description of the global cohort. European Respiratory Society. DOI: 10.1183/13993003.02538-2021
  23. Wulandari, Endang, W., Ronoatmodjo, S., Salama, N. (2021). Hubungan Komorbid Hipertensi dengan Kematian pada Kasus Konfirmasi COVID-19 di DKI Jakarta, Maret-Agustus 2020. Jurnal Ilmu Kesehatan Masyarakat. http://journals.stikim.ac.id/index.php/jikm